DC-based HHP lung cancer vaccine exhibited higher expression of CD80 and CD83 when stimulated with CD40L-expressing A549 in comparison to DC-based HHP lung cancer vaccine incubated with non-transfected A549. The gene discussed is CD80; the disease is lung cancer.